In conclusion, two trends are observed regarding proinflammatory cytokines or mediators; (1) either their role in cancer progression is generally protumoral, such as IL-6, IL-1β, or PGE2, or (2) their function in cancer progression is ambiguous, such as for TNFα and IFNγ. The gene discussed is IL6; the disease is cancer.